HCA Healthcare stock trades at EUR 381.65 as views diverge

Published on 09/29/2026 at 15:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

HCA Healthcare stock faces a Market Perform call from Raymond James dated September 28, 2026. Q2 revenue was USD 20.23 billion and rose 8.70 percent year over year.

Fotorealistisches Krankenhaus-Außengebäude mit Ambulanzen am Haupteingang bei Sonnenuntergang — HCA Healthcare US40412C1018 zeigt einen modernen Krankenhaus Campus mit Notaufnahme bei goldenem Abendlicht, Illustration mit AI erstellt.

HCA Healthcare (ISIN US40412C1018) was trading at EUR 381.65 at Lang & Schwarz on September 29, 2026, up 0.33 percent from the prior close of EUR 380.40. The latest analyst signal came from Investing.com on September 28, 2026, when Raymond James initiated coverage with a Market Perform rating.

Analyst caution meets earnings strength

Raymond James cited Medicaid work requirements, future site-neutral payment caps and unfavorable exchange trends as industry headwinds, according to Investing.com. The firm also said HCA needs material acceleration in the second half of 2026, making execution the key counterweight to the companys scale.

The operating figures tell a firmer story. MarketBeat reported second-quarter 2026 EPS of USD 7.59 against a USD 7.56 consensus estimate, while revenue reached USD 20.23 billion versus USD 19.76 billion expected. Revenue increased 8.70 percent from the comparable period.

Consensus target stays above the quote

MarketBeat said 14 of 23 analysts rated the stock Buy, eight rated it Hold and one rated it Sell on September 22, 2026. The average 12-month target was USD 462.27, while the latest NYSE context showed HCA at USD 432.60 on September 28, 2026 at 4:00 p.m. EDT.

That spread places the consensus target USD 29.67 above the NYSE price, but it does not erase the operating risks identified by Raymond James. HCA also declared a quarterly dividend of USD 0.78, payable September 30, 2026, according to MarketBeat.

HCA Healthcare stock holds its ground

HCA Healthcare stock was trading at EUR 381.65 at Lang & Schwarz on September 29, 2026 at 3:11 p.m. CEST, plus 0.33 percent versus the September 28, 2026 prior close of EUR 380.40. The modest euro move contrasts with the debate between solid second-quarter growth and tougher payer and policy conditions.